US 7,524,837 B2
Benzotriazapinone salts and methods for using same
Ahmed F. Abdel-Magid, Ambler, Pa. (US); and Judith H. Cohen, North Wales, Pa. (US)
Assigned to Janssen Pharmaceutica N.V., Beerse (Belgium)
Filed on Apr. 27, 2004, as Appl. No. 10/833,232.
Claims priority of provisional application 60/469659, filed on May 12, 2003.
Prior Publication US 2005/0026911 A1, Feb. 03, 2005
Int. Cl. C07D 401/04 (2006.01)
U.S. Cl. 514—183  [540/501] 15 Claims
 
1. A pharmaceutically acceptable choline salt of a compound of formula (I)

OG Complex Work Unit Drawing
wherein:
W is N or N+—O;
R1 and R5 are independently H, C1 to C6 alkyl, (C1 to C6 alkyl)oxy, mercapto, (C1 to C6 alkyl)mercapto, carboxy, carboxy(C1 to C6 alkyl), formyl, (C1 to C6 alkyl)carbonyl, (C1 to C6 alkyl)oxycarbonyl, (C1 to C6 alkyl)carbonyloxy, nitro, trihalomethyl, hydroxy, hydroxy(C1 to C6 alkyl), amino, (C1 to C6 alkyl)amino, di(C1 to C6 alkyl)amino, aminocarbonyl, halo, halo(C1 to C6 alkyl), aminosulfonyl, (C1 to C6 alkyl)sulfonylamino, (C1 to C6 alkyl)aminocarbonyl, di(C1 to C6 alkyl)aminocarbonyl, [N-Z](C1 to C6 alkyl)carbonylamino, formyloxy, formamido, (C1 to C6 alkyl)aminosulfonyl, di(C1 to C6 alkyl)aminosulfonyl, [N-Z](C1 to C6 alkyl)sulfonylamino or cyano; or R1 and R5 together form a methylenedioxy group;
R2 is H or a C1 to C18 alkyl, alkenyl, alkynyl, cycloalkyl, polycycloalkyl, cycloalkenyl, or aryl group, or a combination thereof, optionally substituted with 1, 2, or 3 -L-Q2 groups up to three C atoms of each alkyl, alkenyl, alkynyl, cycloalkyl, polycycloalkyl, cycloalkenyl, or aryl group may optionally be replaced by N, O and/or S atoms;
R3 is —(CR11R12)m—X—(CR13R14)p—R9;
m is 0, 1, 2, 3 or 4;
p is 0, 1 or 2;
X is a bond, —CR15═CR16—, —C≡C—, C(O)NH, NHC(O), C(O)NMe, NMeC(O), C(O)O, NHC(O)NH, NHC(O)O, OC(O)NH, NH, O, CO, SO2, SO2NH, C(O)NHNH,

OG Complex Work Unit Drawing
R9 is H; C1 to C6 alkyl; or phenyl, naphthyl, pyridyl, benzimidazolyl, indazolyl, quinolinyl, isoquinolinyl, tetrahydroisoquinolinyl, indolinyl, isoindolinyl, indolyl, isoindolyl or 2-pyridonyl substituted with
-L-Q
wherein:
L is a bond, or a group of the formula —(CR17R18)v—Y—(CR17R18)w, wherein v and w are independently 0, 1, 2 or 3, and Y is a bond, —CR15═CR16—, phenyl, furanyl, thiophenyl, pyrrolyl, thiazolyl, imidazolyl, oxazolyl, isoxazolyl, pyrazolyl, isoxazolonyl, piperazinyl, piperidinyl, morpholinyl, pyrrolidinyl, isothiazolyl, triazolyl, oxadiazolyl, thiadiazolyl, pyridyl or pyridazyl; and
Q is 5-oxo-2,5-dihydro[1,2,4]oxadiazolyl;
Q2 is H, (C1 to C6 alkyl)oxy, [N-Z](C1 to C6 alkyl)oxy(C1 to C6 alkyl)amino, mercapto, (C1 to C6 alkyl)mercapto, carboxy(C1 to C6 alkyl)thiol, carboxy, carboxy(C1 to C6 alkyl), carboxy(C1 to C6 alkenyl), [N-Z]carboxy(C1 to C6 alkyl)amino, carboxy(C1 to C6 alkyl)oxy, formyl, (C1 to C6 alkyl)carbonyl, (C1 to C6 cycloalkyl)carbonyl, (C1 to C6 alkyl)oxycarbonyl, (C1 to C6 alkyl)carbonyloxy, nitro, trihalomethyl, hydroxy, amino, [N-Z](C1 to C6 alkyl)amino, aminocarbonyl, (C1 to C6 alkyl)aminocarbonyl, di(C1 to C6 alkyl)aminocarbonyl, [N-Z](C1 to C6 alkyl)carbonylamino, C5 to C8 cycloalkyl, [N-Z](C1 to C6 alkyl)carbonyl(C1 to C6 alkyl)amino, halo, halo(C1 to C6 alkyl), sulfamoyl, [N-Z](C1 to C6 alkyl)sulfonylamino, (C1 to C6 alkyl)sulfonylaminocarbonyl, carboxy(C1 to C6 alkyl)sulfonyl, carboxy(C1 to C6 alkyl)sulfinyl, tetrazolyl, [N-Z]tetrazolylamino, cyano, amidino, amidinothio, SO3H, formyloxy, formamido, C3 to C8 cycloalkyl, (C1 to C6 alkyl)sulphamoyl, di(C1 to C6 alkyl)sulphamoyl, (C1 to C6 alkyl)carbonylaminosulfonyl, 5-oxo-2,5-dihydro[1,2,4]oxadiazolyl, carboxy(C1 to C6 alkyl)carbonylamino, tetrazolyl(C1 to C6 alkyl)thio, [N-Z]tetrazolyl(C1 to C6 alkyl)amino, 5-oxo-2,5-dihydro[1,2,4]thiadiazolyl, 5-oxo-1,2-dihydro[1,2,4]triazolyl, [N-Z](C1 to C6 alkyl)amino(C1 to C6 alkyl)amino, or a group of the formula

OG Complex Work Unit Drawing
P is O, S or NR19;
Z is H, C1 to C6 alkyl, t-butoxycarbonyl, acetyl, benzoyl or benzyl;
R4 is H or a C1 to C18 alkyl, alkenyl, alkynyl, cycloalkyl, polycycloalkyl, cycloalkenyl, or aryl group, or a combination thereof, optionally substituted with 1, 2, or 3 -L-Q2 groups wherein up to three C atoms of each alkyl, alkenyl, alkynyl, cycloalkyl, polycycloalkyl, cycloalkenyl, or aryl group may optionally be replaced by N, O and/or S atoms;
R11, R12, R13, R14, R15, R17, R18 and R19 are independently H or C1 to C3 alkyl; and
R16 is H, C1 to C3 alkyl, or acetylamino.